iRhythm Technologies, Inc.

iRhythm Technologies, Inc.

Company Details

WebsiteLinkedIn

Status: Public

Employees: 1,001-10,000

Location:

650 Townsend St., Ste. 500, San Francisco, CA 94103, US

Type:

sample

sample

sample

Technology:

sample

sample

sample

About: iRhythm Technologies, Inc. is a digital healthcare company focused on cardiac arrhythmia detection and management using AI-driven wearable technology. The company combines wearable biosensors, cloud-based analytics, and proprietary AI algorithms to analyze heart rhythm data, having served over 8 million patients and analyzed more than 1.5 billion hours of heartbeat data. The flagship product, Zio by iRhythm, is a comprehensive cardiac monitoring platform that includes discreet, long-term ECG monitors and cloud-based analytics that produce clinically actionable reports. iRhythm also offers end-to-end monitoring services for healthcare providers, streamlining the arrhythmia detection process. The company targets cardiologists and primary care physicians, as well as patients needing long-term cardiac monitoring, particularly those at risk of undiagnosed arrhythmias. Under the leadership of CEO Quentin Blackford, iRhythm aims to enhance patient care and reduce healthcare costs through early detection and personalized solutions.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
BiopharmIQ
iRhythm Technologies, Inc. | Active clinical trials on ClinicalTrials.gov

Active Clinical Trials Count | 0

No Active Trials Found On ClinicalTrials.gov.